Raquel N Taddei
Overview
Explore the profile of Raquel N Taddei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taddei R, E Duff K
EBioMedicine
. 2025 Feb;
112:105557.
PMID: 39891995
Synapse preservation is key for healthy cognitive ageing, and synapse loss represents a critical anatomical basis of cognitive dysfunction in Alzheimer's disease (AD), predicting dementia onset, severity, and progression. Synapse...
2.
Perbet R, Mate de Gerando A, Glynn C, Donahue C, Gaona A, Taddei R, et al.
J Neuropathol Exp Neurol
. 2024 Jun;
83(10):870-881.
PMID: 38917443
Proteins exhibiting prion-like properties are implicated in tauopathies. The prion-like traits of tau influence disease progression and correlate with severity. Techniques to measure tau bioactivity such as RT-QuIC and biosensor...
3.
Taddei R, Perbet R, Mate de Gerando A, Wiedmer A, Sanchez-Mico M, Stewart T, et al.
JAMA Neurol
. 2023 Oct;
80(11):1209-1221.
PMID: 37812432
Importance: Factors associated with synapse loss beyond amyloid-β plaques and neurofibrillary tangles may more closely correlate with the emergence of cognitive deficits in Alzheimer disease (AD) and be relevant for...
4.
Taddei R, Sanchez-Mico M, Bonnar O, Connors T, Gaona A, Denbow D, et al.
Acta Neuropathol Commun
. 2022 May;
10(1):72.
PMID: 35534858
Clinico-pathological correlation studies show that some otherwise healthy elderly individuals who never developed cognitive impairment harbor a burden of Alzheimer's disease lesions (plaques and tangles) that would be expected to...
5.
van Wamelen D, Taddei R, Calvano A, Titova N, Leta V, Shtuchniy I, et al.
J Parkinsons Dis
. 2020 May;
10(3):1003-1010.
PMID: 32444561
Background: Previous studies have identified low serum uric acid (SUA) levels as a risk factor for the development of Parkinson's disease (PD). Prodromal PD mainly manifests as a complex of...
6.
Taddei R, Cankaya S, Dhaliwal S, Chaudhuri K
Parkinsons Dis
. 2017 Nov;
2017:3256542.
PMID: 29104810
Investigation into neuropsychiatric symptoms in Parkinson's disease (PD) is sparse and current drug development is mainly focused on the motor aspect of PD. The tight association of psychosis with an...
7.
Murer T, Imbach L, Hackius M, Taddei R, Werth E, Poryazova R, et al.
Sleep
. 2017 Oct;
40(12).
PMID: 29069490
Study Objectives: Multiple sleep onset rapid eye movement (R) periods (SOREMPs) and a mean sleep latency of ≤8 minutes on the multiple sleep latency test (MSLT) are diagnostic criteria of...
8.
Rosa-Grilo M, Qamar M, Taddei R, Pagonabarraga J, Kulisevsky J, Sauerbier A, et al.
NPJ Parkinsons Dis
. 2017 Sep;
3:28.
PMID: 28890931
A wide range of sleep dysfunction complicates Parkinson's disease during its course from prodromal to palliative stage. It is now increasingly acknowledged that sleep disturbances are thus integral to the...
9.
Schrag A, Taddei R
Int Rev Neurobiol
. 2017 Aug;
133:623-655.
PMID: 28802935
Depression and anxiety are some of the most common comorbidities arising in patients with Parkinson's disease. However, their timely recognition and diagnosis are often hindered by overlap with other somatic...
10.
Taddei R, Spinnato F, Jenner P
Int Rev Neurobiol
. 2017 May;
132:407-452.
PMID: 28554417
Motor symptoms are core features of Parkinson's disease, while nonmotor symptoms are present from the prodromal stage. Management strategies for the motor symptoms of Parkinson's disease have been widely researched...